Third Quarter 2024 Highlights
- Revenues were
RMB239.4 million (US$34.1 million ), compared withRMB261.5 million in the same period last year. - Gross profit was
RMB163.9 million (US$23.4 million ), compared withRMB186.6 million in the same period last year. - Operating income was
RMB20.7 million (US$2.9 million ), compared withRMB40.4 million in the same period last year. - Net income was
RMB25.1 million (US$3.6 million ), compared withRMB51.9 million in the same period last year. - Average total MAUs[1] reached a record-high of 29.12 million, a year-over-year increase of 14.8%.
[1] “Average total MAUs” refers to the monthly average of the sum of the MAUs of each of the Company’s apps during a specific period, which is counted based on the number of unique mobile devices through which such app is accessed at least once in a given month, and duplicate access to different apps is not eliminated from the total MAUs calculation. |
Dr. Peng Dai, Director and Chief Executive Officer of iHuman, commented, “In the third quarter, we continued to see robust user demand for our products, driving average total MAUs to another record high of 29.12 million, representing a year-over-year increase of 14.8%. This growth underscores the effectiveness of our product strategy focused on innovation, overseas market expansion, and responsiveness to evolving market dynamics.
Domestically, we further strengthened our market leadership by enhancing our product portfolio with the launch of iHuman Chinese Reading. This new offering aims to cultivate an interest in Chinese reading, enhance literacy and verbal skills, and deepen children’s understanding of the Chinese culture. Developed by the same team behind our highly acclaimed iHuman Chinese app, iHuman Chinese Reading continues our proud tradition and commitment to excellent content and innovative design. The course features a leveled reading system that facilitates gradual progress in Chinese proficiency and offers a rich variety of content formats, such as ancient Chinese poems, interactive storybooks, and online study tours.
Building on our foundation, we expanded our content library by strengthening ties with influential industry players and leveraged our advanced technology to create richer and more immersive experiences for children. For instance, through our previously announced strategic partnership with Children’s Fun Publishing Co. Ltd., a leading children’s book publisher in
We also continued to roll out updates across other app products. For example, we added two new themes to iHuman Magic Thinking: “Sudoku” and “Thinking Logic.” “Sudoku” introduces children to Sudoku rules and mathematical concepts through short, animated stories and interactive challenges, and “Thinking Logic” engages them with a detective story series designed to sharpen judgment, analytical thinking, and problem-solving abilities.
On the international front, we enriched our portfolio with fresh content and features to boost user engagement and expand our global reach. Aha World received several updates, adding even more fun and adventure to its ever-expanding fantasy world. Children can now explore the “Love Animal Shelter,” where they can adopt, wash, and care for adorable virtual pets and enjoy an immersive and joyful pet ownership experience. For those captivated by the mystical, we introduced themes like “Magic School“ and “
Looking ahead, we remain focused on enhancing our diverse portfolio across markets to better promote children’s holistic development while advancing our sustainable growth initiatives,” concluded
Ms.
Beyond consumer-facing products, we have also built a robust B2B model that currently supports nearly 10,000 kindergartens and institutions across
Third Quarter 2024 Unaudited Financial Results
Revenues
Revenues were
Average total MAUs for the quarter were 29.12 million, an increase of 14.8% year-over-year from 25.36 million in the same period last year, primarily due to the effective execution of our user acquisition strategy and ongoing product innovation.
Cost of Revenues
Cost of revenues was
Gross Profit and Gross Margin
Gross profit was
Operating Expenses
Total (EPA:) operating expenses were
Research and development expenses were
Sales and marketing expenses were
General and administrative expenses were
Operating Income
Operating income was
Net Income
Net income was
Basic and diluted net income per ADS were
Deferred Revenue and Customer Advances
Deferred revenue and customer advances were
Cash, Cash Equivalents and Short-term Investments
Cash, cash equivalents and short-term investments were
Extension of Share Repurchase Program
Given its confidence in the Company’s business prospects, the board of directors (the “Board”) has authorized an extension of the Company’s existing share repurchase program, as authorized in
Exchange Rate Information
The
Non-GAAP Financial Measures
iHuman considers and uses non-GAAP financial measures, such as adjusted operating income, adjusted net income and adjusted diluted net income per ADS, as supplemental metrics in reviewing and assessing its operating performance and formulating its business plan. The presentation of non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in
Non-GAAP financial measures are not defined under
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and similar statements. Statements that are not historical facts, including statements about iHuman’s beliefs and expectations, are forward-looking statements. Among other things, the description of the management’s quotations in this announcement contains forward-looking statements. iHuman may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC“), in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: iHuman’s growth strategies; its future business development, financial condition and results of operations; its ability to continue to attract and retain users, convert non-paying users into paying users and increase the spending of paying users, the trends in, and size of, the market in which iHuman operates; its expectations regarding demand for, and market acceptance of, its products and services; its expectations regarding its relationships with business partners; general economic and business conditions; regulatory environment; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in iHuman’s filings with the SEC. All information provided in this press release is as of the date of this press release, and iHuman does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
About iHuman Inc.
iHuman Inc. is a leading provider of tech-powered, intellectual development products in
For more information about iHuman, please visit https://ir.ihuman.com/.
For investor and media enquiries, please contact:
iHuman Inc.
Mr. Justin Zhang
Investor Relations Director
Phone: +86 10 5780-6606
E-mail: ir@ihuman.com
Christensen
In
Ms.
E-mail: alice.li@christensencomms.com
In the US
Ms.
E-mail: linda.bergkamp@christensencomms.com
iHuman Inc. |
|||||
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS |
|||||
(Amounts in thousands of Renminbi (“RMB”) and |
|||||
except for number of shares, ADSs, per share and per ADS data) |
|||||
|
|
|
|||
2023 |
2024 |
2024 |
|||
RMB |
RMB |
US$ |
|||
ASSETS |
|||||
Current assets |
|||||
Cash and cash equivalents |
1,213,767 |
651,684 |
92,864 |
||
Short-term investments |
– |
516,910 |
73,659 |
||
Accounts receivable, net |
60,832 |
66,376 |
9,459 |
||
Inventories, net |
16,518 |
16,882 |
2,406 |
||
Amounts due from related parties |
1,810 |
2,099 |
299 |
||
Prepayments and other current assets |
89,511 |
102,036 |
14,540 |
||
Total current assets |
1,382,438 |
1,355,987 |
193,227 |
||
Non-current assets |
|||||
Property and equipment, net |
6,169 |
3,893 |
555 |
||
Intangible assets, net |
23,245 |
21,121 |
3,010 |
||
Operating lease right-of-use assets |
3,648 |
2,376 |
339 |
||
Long-term investment |
26,333 |
26,333 |
3,752 |
||
Other non-current assets |
8,662 |
10,937 |
1,556 |
||
Total non-current assets |
68,057 |
64,660 |
9,212 |
||
Total assets |
1,450,495 |
1,420,647 |
202,439 |
||
LIABILITIES |
|||||
Current liabilities |
|||||
Accounts payable |
22,139 |
25,761 |
3,671 |
||
Deferred revenue and customer advances |
318,587 |
298,896 |
42,592 |
||
Amounts due to related parties |
4,428 |
20,719 |
2,952 |
||
Accrued expenses and other current liabilities |
143,677 |
116,382 |
16,584 |
||
Dividend payable |
– |
30,139 |
4,295 |
||
Current operating lease liabilities |
1,927 |
1,683 |
240 |
||
Total current liabilities |
490,758 |
493,580 |
70,334 |
||
Non-current liabilities |
|||||
Non-current operating lease liabilities |
1,933 |
735 |
105 |
||
Total non-current liabilities |
1,933 |
735 |
105 |
||
Total liabilities |
492,691 |
494,315 |
70,439 |
||
SHAREHOLDERS’ EQUITY |
|||||
Ordinary shares (par value of |
185 |
185 |
26 |
||
Additional paid-in capital |
1,088,628 |
996,089 |
141,942 |
||
Treasury stock |
(16,665) |
(23,579) |
(3,360) |
||
Statutory reserves |
8,164 |
8,164 |
1,163 |
||
Accumulated other comprehensive income |
17,955 |
13,828 |
1,970 |
||
Accumulated deficit |
(140,463) |
(68,355) |
(9,741) |
||
Total shareholders’ equity |
957,804 |
926,332 |
132,000 |
||
Total liabilities and shareholders’ equity |
1,450,495 |
1,420,647 |
202,439 |
iHuman Inc. |
|||||||||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
|||||||||||||
(Amounts in thousands of Renminbi (“RMB”) and |
|||||||||||||
except for number of shares, ADSs, per share and per ADS data) |
|||||||||||||
For the three months ended |
For the nine months ended |
||||||||||||
|
|
|
|
|
|
|
|||||||
2023 |
2024 |
2024 |
2024 |
2023 |
2024 |
2024 |
|||||||
RMB |
RMB |
RMB |
US$ |
RMB |
RMB |
US$ |
|||||||
Revenues |
261,496 |
215,107 |
239,407 |
34,115 |
767,692 |
689,517 |
98,255 |
||||||
Cost of revenues |
(74,871) |
(63,372) |
(75,541) |
(10,765) |
(224,667) |
(205,805) |
(29,327) |
||||||
Gross profit |
186,625 |
151,735 |
163,866 |
23,350 |
543,025 |
483,712 |
68,928 |
||||||
Operating expenses |
|||||||||||||
Research and development expenses |
(66,168) |
(57,219) |
(59,307) |
(8,451) |
(191,253) |
(184,449) |
(26,284) |
||||||
Sales and marketing expenses |
(53,994) |
(51,263) |
(60,863) |
(8,673) |
(134,993) |
(167,121) |
(23,815) |
||||||
General and administrative expenses |
(26,070) |
(24,426) |
(22,998) |
(3,277) |
(78,787) |
(75,148) |
(10,709) |
||||||
Total operating expenses |
(146,232) |
(132,908) |
(143,168) |
(20,401) |
(405,033) |
(426,718) |
(60,808) |
||||||
Operating income |
40,393 |
18,827 |
20,698 |
2,949 |
137,992 |
56,994 |
8,120 |
||||||
Other income, net |
19,507 |
9,410 |
8,024 |
1,143 |
33,721 |
26,444 |
3,768 |
||||||
Income before income taxes |
59,900 |
28,237 |
28,722 |
4,092 |
171,713 |
83,438 |
11,888 |
||||||
Income tax expenses |
(7,984) |
(3,574) |
(3,579) |
(510) |
(24,077) |
(11,330) |
(1,615) |
||||||
Net income |
51,916 |
24,663 |
25,143 |
3,582 |
147,636 |
72,108 |
10,273 |
||||||
Net income per ADS: |
|||||||||||||
– Basic |
0.98 |
0.47 |
0.48 |
0.07 |
2.79 |
1.37 |
0.20 |
||||||
– Diluted |
0.95 |
0.45 |
0.47 |
0.07 |
2.70 |
1.33 |
0.19 |
||||||
Weighted average number of ADSs: |
|||||||||||||
– Basic |
52,747,426 |
52,496,541 |
52,283,334 |
52,283,334 |
52,834,352 |
52,502,206 |
52,502,206 |
||||||
– Diluted |
54,772,536 |
54,295,419 |
54,011,420 |
54,011,420 |
54,753,124 |
54,332,011 |
54,332,011 |
||||||
Total share-based compensation expenses included in: |
|||||||||||||
Cost of revenues |
67 |
26 |
22 |
3 |
235 |
88 |
13 |
||||||
Research and development expenses |
1,160 |
348 |
225 |
32 |
2,940 |
1,030 |
147 |
||||||
Sales and marketing expenses |
147 |
45 |
39 |
6 |
585 |
130 |
19 |
||||||
General and administrative expenses |
1,105 |
392 |
329 |
47 |
3,557 |
1,022 |
146 |
||||||
iHuman Inc. |
|||||||||||||
UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP RESULTS |
|||||||||||||
(Amounts in thousands of Renminbi (“RMB”) and |
|||||||||||||
except for number of shares, ADSs, per share and per ADS data) |
|||||||||||||
For the three months ended |
For the nine months ended |
||||||||||||
|
|
|
|
|
|
|
|||||||
2023 |
2024 |
2024 |
2024 |
2023 |
2024 |
2024 |
|||||||
RMB |
RMB |
RMB |
US$ |
RMB |
RMB |
US$ |
|||||||
Operating income |
40,393 |
18,827 |
20,698 |
2,949 |
137,992 |
56,994 |
8,120 |
||||||
Share-based compensation expenses |
2,479 |
811 |
615 |
88 |
7,317 |
2,270 |
325 |
||||||
Adjusted operating income |
42,872 |
19,638 |
21,313 |
3,037 |
145,309 |
59,264 |
8,445 |
||||||
Net income |
51,916 |
24,663 |
25,143 |
3,582 |
147,636 |
72,108 |
10,273 |
||||||
Share-based compensation expenses |
2,479 |
811 |
615 |
88 |
7,317 |
2,270 |
325 |
||||||
Adjusted net income |
54,395 |
25,474 |
25,758 |
3,670 |
154,953 |
74,378 |
10,598 |
||||||
Diluted net income per ADS |
0.95 |
0.45 |
0.47 |
0.07 |
2.70 |
1.33 |
0.19 |
||||||
Impact of non-GAAP adjustments |
0.04 |
0.02 |
0.01 |
0.00 |
0.13 |
0.04 |
0.01 |
||||||
Adjusted diluted net income per ADS |
0.99 |
0.47 |
0.48 |
0.07 |
2.83 |
1.37 |
0.20 |
||||||
Weighted average number of ADSs “ diluted |
54,772,536 |
54,295,419 |
54,011,420 |
54,011,420 |
54,753,124 |
54,332,011 |
54,332,011 |
||||||
Weighted average number of ADSs “ adjusted |
54,772,536 |
54,295,419 |
54,011,420 |
54,011,420 |
54,753,124 |
54,332,011 |
54,332,011 |